EXEL:NASDAQ
Exelixis Inc
$69.00
arrow_downward
-1.20%(-0.84) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EXEL...
Open
$69.87
High
$69.94
Low
$68.70
Mkt. cap
16.84B
Avg. vol.
2.78M
Volume
1.52M
P/E ratio
20.65
52-wk high
$73.69
52-wk low
$39.71
EPS
$3.34
Beta
0.45
Shares outstanding
244.01M
No. of employees
1K
Open
$69.87
High
$69.94
Low
$68.70
Mkt. cap
16.84B
Avg. vol.
2.78M
Volume
1.52M
P/E ratio
20.65
52-wk high
$73.69
52-wk low
$39.71
EPS
$3.34
Beta
0.45
Shares outstanding
244.01M
No. of employees
1K
News stories
From web sources and news partners
TradingView
·
8 hours ago
Exelixis, Inc. Stock 12‑Month Price Target Raised to $62.08, Implies 10% Downside
Yahoo Finance
·
1 day ago
Exelixis Has 2 Major Catalysts Coming by March 2027. Here's What Investors Should Watch.
Profile
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
About Exelixis Inc
CEOMichael M. Morrissey
Employees1.08K
FoundedNov 15, 1994
HeadquartersAlameda, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteexelixis.com